Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma

N Engl J Med. 2011 Jun 30;364(26):2473-5. doi: 10.1056/NEJMp1104375.

Authors

Badrul A Chowdhury¹, Sally M Seymour, Mark S Levenson

Affiliation

¹ Division of Pulmonary, Allergy, and Rheumatology Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

PMID: 21714647
DOI: 10.1056/NEJMp1104375

No abstract available

MeSH terms

Administration, Inhalation
Adolescent
Adrenal Cortex Hormones / therapeutic use*
Adrenergic beta-Agonists / adverse effects*
Adrenergic beta-Agonists / therapeutic use
Adult
Asthma / drug therapy*
Bronchodilator Agents / adverse effects*
Bronchodilator Agents / therapeutic use
Child
Child, Preschool
Clinical Trials as Topic*
Drug Approval
Drug Evaluation
Drug Therapy, Combination
Humans
United States
United States Food and Drug Administration

Substances

Adrenal Cortex Hormones
Adrenergic beta-Agonists
Bronchodilator Agents